EcoDrugPlus

Ribosomal Protein L39

Ensembl ID : ENSMMNG00015017247
Gene Symbol: RPL39
2 Cross references
167 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSMMNG00015012222
Gene Symbol: RPL6
2 Cross references
371 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSMMNG00015002563
Gene Symbol: RPL7
2 Cross references
170 Possible Orthologues:

Ribosomal Protein S13

Ensembl ID : ENSMMNG00015021335
Gene Symbol: RPS13
3 Cross references
184 Possible Orthologues:

Ribosomal Protein S14

Ensembl ID : ENSMMNG00015002549
Gene Symbol: RPS14
3 Cross references
262 Possible Orthologues:

Ribosomal Protein S15

Ensembl ID : ENSMMNG00015002435
Gene Symbol: RPS15
2 Cross references
152 Possible Orthologues:

Ribosomal Protein S16

Ensembl ID : ENSMMNG00015000939
Gene Symbol: RPS16
3 Cross references
277 Possible Orthologues:

Ribosomal Protein S2

Ensembl ID : ENSMMNG00015003862
Gene Symbol: RPS2
2 Cross references
172 Possible Orthologues:

Ribosomal Protein S20

Ensembl ID : ENSMMNG00015015116
Gene Symbol: RPS20
3 Cross references
181 Possible Orthologues:

Ribosomal Protein S21

Ensembl ID : ENSMMNG00015003199
Gene Symbol: RPS21
3 Cross references
210 Possible Orthologues:

Ribosomal Protein S23

Ensembl ID : ENSMMNG00015009087
Gene Symbol: RPS23
2 Cross references
177 Possible Orthologues:

Ribosomal Protein S25

Ensembl ID : ENSMMNG00015021484
Gene Symbol: RPS25
3 Cross references
140 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).